Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > If value and blig

<< Previous

Bullboard Posts

Next >>

Comment by Valuehunter72on Jun 25, 2020 5:06pm

53 Views

Post# 31192512

RE:If value and blig

I will apologize to nobody.

The CEO has a set of rules to follow.

The exchange has an obligation to ensure PP's are conducted fairly.

The OSC has a job to watch out for manipulation and non disclosure.

Make it right DG and perhaps I will add another 10,000 shares.

Did M Partners get their final approval?

<< Previous

Bullboard Posts

Next >>

Canadian psychedelic stock to supply MDMA to Yale